Artelo Biosciences
$9.21
34
+$1.63+21.47% Today
Statistics
Day High
9.39
Day Low
7.2
52W High
85.8
52W Low
2.96
Volume
558,340
Avg. Volume
2,796,228
Mkt Cap
18.59M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19MayExpected
Expected EPS
-0.78
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-19.65MNet Income
Analyst Ratings
$0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ARTL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap148.9M
Aurora Cannabis
ACB
Mkt Cap280.01M
Tilray Brands
TLRY
Mkt Cap1.5B
Canopy Growth
CGC
Mkt Cap418.51M
Curaleaf
CURLF
Mkt Cap2.16B
About
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
Show more...
CEO
Mr. Gregory D. Gorgas M.B.A.
Employees
6
Country
US
ISIN
US04301G7060
Listings
0 Comments
Share your thoughts
FAQ
What is Artelo Biosciences stock price today?▼
The current price of ARTL is $9.21 USD — it has increased by +21.47% in the past 24 hours. Watch Artelo Biosciences stock price performance more closely on the chart.
What is Artelo Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Artelo Biosciences stocks are traded under the ticker ARTL.
Is Artelo Biosciences stock price growing?▼
ARTL stock has risen by +84.47% compared to the previous week, the month change is a +150.62% rise, over the last year Artelo Biosciences has showed a +246.78% increase.
What is Artelo Biosciences market cap?▼
Today Artelo Biosciences has the market capitalization of 18.59M
When is the next Artelo Biosciences earnings date?▼
Artelo Biosciences is going to release the next earnings report on May 19, 2026.
What were Artelo Biosciences earnings last quarter?▼
ARTL earnings for the last quarter are -6.66 USD per share, whereas the estimation was -4.71 USD resulting in a -41.4% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Artelo Biosciences revenue for the last year?▼
Artelo Biosciences revenue for the last year amounts to 0 USD.
What is Artelo Biosciences net income for the last year?▼
ARTL net income for the last year is -19.65M USD.
How many employees does Artelo Biosciences have?▼
As of April 01, 2026, the company has 6 employees.
In which sector is Artelo Biosciences located?▼
Artelo Biosciences operates in the Health Care sector.
When did Artelo Biosciences complete a stock split?▼
The last stock split for Artelo Biosciences was on March 10, 2026 with a ratio of 1:3.
Where is Artelo Biosciences headquartered?▼
Artelo Biosciences is headquartered in Solana Beach, US.